The effect of TAO expression on PCD-like phenomenon development and drug resistance in Trypanosoma brucei

Parasitology International

Volumn 55, Issue 2, 2006, Pages 135-142

  Tsuda, Akiko ^a   Witola, William H ^a   Konnai, Satoru ^a   Ohashi, Kazuhiko ^a   Onuma, Misao ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antrycide; Drug resistance; Programmed cell death; Suramin; Trypanosoma brucei; Trypanosome alternative oxidase

Indexed keywords

OXIDOREDUCTASE; QUINAPYRAMINE; REACTIVE OXYGEN METABOLITE; SURAMIN; TRYPANOSOME ALTERNATIVE OXIDASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CORRELATION ANALYSIS; GENE OVEREXPRESSION; GENETIC ENGINEERING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA BRUCEI; WILD TYPE;

ANIMALS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IN SITU NICK-END LABELING; OXIDOREDUCTASES; PARASITIC SENSITIVITY TESTS; QUINOLINIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; SURAMIN; TIME FACTORS; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

ANIMALIA; TRYPANOSOMA BRUCEI;

EID: 33646020662     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2006.01.001     Document Type: Article

References (35)

1. Geerts S., Holmes P.H., Diall O., and Eisler M.C. African bovine trypanosomiasis: the problem of drug resistance. Trends Parasitol 17 (2001) 25-28
2. Mäser P., Lüscher A., and Kaminsky R. Drug transport and drug resistance in African trypanosomes. Drug Resist Updat 6 (2003) 281-290
3. Witola W.H., Inoue N., Ohashi K., and Onuma M. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate. Exp Parasitol 107 (2004) 47-57
4. Wilson K., Berens R.L., Sifri C.D., and Ullman B. Amplification of the inosinate dehydrogenase gene in Trypanosoma brucei gambiense due to an increase in chromosome copy number. J Biol Chem 269 (1994) 28979-28987
5. Fairlamb A.H., Smith K., and Hunter KJ. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei. Mol Biochem Parasitol 53 (1992) 223-232
6. Debrabant A., Lee N., Bertholet S., Duncan R., and Nakhasi H.L. Programmed cell death in trypanosomatids and other unicellular organisms. Int J Parasitol 33 (2003) 257-267
7. Johnstone R.W., Ruefli A.A., and Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108 (2002) 153-164
8. Picot S., Burnod J., Bracchi C., Chumpitazi B.F.F., and Ambroise-Thomas P. Apoptosis related to chloroquine sensitivity of the human malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg 91 (1997) 590-591
9. Rousselot P., Labaume S., Marolleau J.P., Larghero J., Noguera M.H., Brouet J.C., et al. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 59 (1999) 1041-1048
10. Koshiuka K., Elstner E., Williamson E., Said J.W., Tada Y., and Koeffler HP. Novel therapeutic approach: organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo. Bri J Cancer 82 (2000) 452-458
11. Wang Z.G., Rivi R., Delva L., König A., Scheinberg D.A., Gambacorti-Passerini C., et al. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARa independent manner. Blood 92 (1998) 1497-1504
12. Bajenova O., Tang B., Pearse R., Feinman R., Childs B.H., and Michaeli J. RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells. Apoptosis 9 (2004) 561-571
13. Mamami-Matsuda M., Rambert J., Malvy D., Lejoly-Boisseau, Daulouède, Thiolat D., et al. Quercetin induces apoptosis of Trypanosoma brucei gambiense and decrease the proinflammatory response of human macrophages. Antimicrob Agents Chemother 48 (2004) 924-929
14. Nkemgu-Njinkeng J., Rosenkranz V., Wink R., and Steverding D. Antitrypanosomal activities of proteasome inhibitors. Antimicrob Agents Chemother 46 (2002) 2038-2040
15. Chaudhuri M., Ajayi W., and Hill G.C. Biochemical and molecular properties of the Trypanosoma brucei alternative oxidase. Mol Biochem Parasitol 95 (1998) 53-68
16. Nihei C., Fukai Y., and Kita K. Trypanosome alternative oxidase as a target of chemotherapy. Biochimi Biophys Acta 1587 (2002) 234-239
17. Fang J., and Beattie D.S. Alternative oxidase present in procyclic Trypanosoma brucei may act to lower the mitochondrial production of superoxide. Arch Biochem Biophys 414 (2003) 294-302
18. Fleury C., Mignotte B., and Vayssière J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84 (2002) 131-141
19. Robinson C.A., and Vanlerberghe G.C. Transgenic plant cells lacking mitochondrial alternative oxidase have increased susceptibility to mitochondria-dependent and-independent pathways of programmed cell death. Plant Physiol 129 (2002) 1908-1920
20. Vanlerberghe G.C., Robinson C.A., and Justine Y.H.Y. Induction of mitochondrial alternative oxidase in response to a cell signal pathway down-regulating the cytochrome pathway prevents programmed cell death. Plant Physiol 129 (2002) 1829-1842
21. Tsuda A., Witola W.H., Ohashi K., and Onuma M. Expression of alternative oxidase inhibits programmed cell death-like phenomenon in bloodstream form of Trypanosoma brucei rhodesiense. Parasitol Int 54 (2005) 243-251
22. Hirumi H., and Hirumi K. Continuous cultivation of Trypanosoma brucei bloodstream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol 75 (1989) 985-989
23. Wirtz E., Leal S., Ochatt C., and Cross G.A. A tightly inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol 99 (1999) 89-101
24. Oyama Y., Hayashi A., Ueha T., and Maekawa K. Characterization of 2',7'-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res 635 (1994) 113-117
25. Cohen J.J. Apoptosis. Immunol Today 14 3 (1993) 126-130
26. Cruchten S.V., and Broeck W.V. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 31 (2002) 214-223
27. Sakahira H., Enari M., Ohsawa Y., Uchiyama Y., and Nagata S. Apoptotic nuclear morphological change without DNA fragmentation. Curr Biol 9 10 (1999) 543-546
28. Negri C., Donzelli M., Bernardi R., Rossi L., Bürkle A., and Scovassi A.I. Multiparametric staining to identify apoptotic human cells. Exp Cell Res 234 (1997) 174-177
29. Summers J.M., and Hawkins S.E. The effect of antrycide of patterns of RNA synthesis in Amoeba discoides. J Cell Sci 30 (1978) 237-250
30. Eisenberger M.A., and Reyno L.M. Suramin. Cancer Treat Rev 20 (1994) 259-273
31. Eichhorst S.T., Krueger A., Müerköster S., Fas S.C., Golks A., Gruetzner U., et al. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med 10 (2004) 602-609
32. Fairlamb A.H., and Bowman I.B.R. Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo. Mol Biochem Parasitol 1 (1980) 315-333
33. Clayton C.E., and Michels P. Metabolic compartmentation in African Trypanosomes. Parasitol Today 12 (1996) 465-471
34. Tielens A.G.M., and Van Hellemond J.J. Differences in energy metabolism between trypanosomatidae. Parasitol Today 14 7 (1998) 265-271
35. Schmitt C.A., Rosenthal C.T., and Lowe S.W. Genetic analysis of chemoresistance in primary murine lymphomas. Nat Med 6 (2000) 1029-1035